Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Reisin

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
British Journal of Biomedical Science|October 17, 2003
Impaired nitric oxide production, brachial artery reactivity and fish oil in offspring of ischaemic heart disease patientsC Yosefy, V Khalamizer, J R Viskoper, et al.
European Journal of Heart Failure|August 21, 2001
Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failureG Cotter, W Kiowski, E Kaluski, et al.
The Journal of Biological Chemistry|May 7, 2002
Voltage dependence and pH regulation of human polycystin-2-mediated cation channel activitySilvia Gonzalez-Perrett, Marisa Batelli, Keetae Kim, et al.
The Journal of Biological Chemistry|April 15, 1994
External ATP and its analogs activate the cystic fibrosis transmembrane conductance regulator by a cyclic AMP-independent mechanismH F Cantiello, A G Prat, I L Reisin, et al.
Revista Do Hospital Das Clinicas|August 1, 1975
[Experimental coronary artery obstruction and heart rate]R Macruz, R Correa Rabelo, L Reisin, et al.
Archives of Internal Medicine|April 1, 1998
Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era: the Israeli Thrombolytic National SurveyD Tanne, S Gottlieb, A Caspi, et al.
The American Journal of Physiology|April 8, 1998
Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulatorH F Cantiello, G R Jackson, C F Grosman, et al.
European Heart Journal|October 1, 1996
Long-term prognosis of patients after a Q wave compared with a non-Q wave first acute myocardial infarction. Data from the SPRINT RegistryS Behar, M Haim, H Hod, et al.
The Journal of Biological Chemistry|July 26, 1996
Renal epithelial protein (Apx) is an actin cytoskeleton-regulated Na+ channelA G Prat, E J Holtzman, D Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2001
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channelS González-Perrett, K Kim, C Ibarra, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
British Journal of Biomedical Science|October 17, 2003
Impaired nitric oxide production, brachial artery reactivity and fish oil in offspring of ischaemic heart disease patientsC Yosefy, V Khalamizer, J R Viskoper, et al.
European Journal of Heart Failure|August 21, 2001
Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failureG Cotter, W Kiowski, E Kaluski, et al.
The Journal of Biological Chemistry|May 7, 2002
Voltage dependence and pH regulation of human polycystin-2-mediated cation channel activitySilvia Gonzalez-Perrett, Marisa Batelli, Keetae Kim, et al.
The Journal of Biological Chemistry|April 15, 1994
External ATP and its analogs activate the cystic fibrosis transmembrane conductance regulator by a cyclic AMP-independent mechanismH F Cantiello, A G Prat, I L Reisin, et al.
Revista Do Hospital Das Clinicas|August 1, 1975
[Experimental coronary artery obstruction and heart rate]R Macruz, R Correa Rabelo, L Reisin, et al.
Archives of Internal Medicine|April 1, 1998
Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era: the Israeli Thrombolytic National SurveyD Tanne, S Gottlieb, A Caspi, et al.
The American Journal of Physiology|April 8, 1998
Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulatorH F Cantiello, G R Jackson, C F Grosman, et al.
European Heart Journal|October 1, 1996
Long-term prognosis of patients after a Q wave compared with a non-Q wave first acute myocardial infarction. Data from the SPRINT RegistryS Behar, M Haim, H Hod, et al.
The Journal of Biological Chemistry|July 26, 1996
Renal epithelial protein (Apx) is an actin cytoskeleton-regulated Na+ channelA G Prat, E J Holtzman, D Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2001
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channelS González-Perrett, K Kim, C Ibarra, et al.
Pageof 6